CCT8L2
Basic information
Region (hg38): 22:16590751-16592810
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CCT8L2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 35 | 41 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 35 | 6 | 1 |
Variants in CCT8L2
This is a list of pathogenic ClinVar variants found in the CCT8L2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
22-16590897-T-A | not specified | Uncertain significance (May 28, 2024) | ||
22-16590908-T-C | not specified | Uncertain significance (Sep 10, 2024) | ||
22-16590942-A-G | not specified | Likely benign (Dec 12, 2023) | ||
22-16590972-G-C | not specified | Uncertain significance (Jul 14, 2024) | ||
22-16590974-C-A | not specified | Uncertain significance (Feb 06, 2024) | ||
22-16590990-C-T | not specified | Uncertain significance (Jul 27, 2022) | ||
22-16591102-T-A | not specified | Uncertain significance (Sep 08, 2024) | ||
22-16591125-G-A | not specified | Likely benign (Feb 05, 2024) | ||
22-16591126-G-T | not specified | Uncertain significance (May 28, 2024) | ||
22-16591133-C-G | not specified | Likely benign (Aug 28, 2023) | ||
22-16591151-A-G | not specified | Uncertain significance (Jan 02, 2024) | ||
22-16591362-C-T | not specified | Uncertain significance (Feb 22, 2023) | ||
22-16591368-C-A | not specified | Uncertain significance (May 16, 2022) | ||
22-16591370-T-C | not specified | Uncertain significance (Jan 03, 2024) | ||
22-16591395-G-A | not specified | Uncertain significance (Feb 22, 2023) | ||
22-16591409-G-A | not specified | Uncertain significance (Nov 10, 2024) | ||
22-16591415-C-T | not specified | Uncertain significance (Oct 17, 2023) | ||
22-16591419-T-A | not specified | Uncertain significance (Jun 22, 2023) | ||
22-16591521-G-T | Benign (Nov 08, 2017) | |||
22-16591560-C-G | not specified | Uncertain significance (Jun 24, 2022) | ||
22-16591567-C-A | not specified | Uncertain significance (Oct 02, 2023) | ||
22-16591611-C-T | not specified | Uncertain significance (Sep 23, 2023) | ||
22-16591614-C-T | not specified | Likely benign (Jan 30, 2024) | ||
22-16591617-T-C | not specified | Uncertain significance (Mar 01, 2024) | ||
22-16591638-T-C | not specified | Uncertain significance (Nov 08, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CCT8L2 | protein_coding | protein_coding | ENST00000359963 | 1 | 2034 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000159 | 0.246 | 0 | 0 | 0 | 0 | 0.00 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.0418 | 311 | 313 | 0.993 | 0.0000178 | 3564 |
Missense in Polyphen | 99 | 96.442 | 1.0265 | 1134 | ||
Synonymous | -0.770 | 146 | 135 | 1.08 | 0.00000820 | 1249 |
Loss of Function | 0.0874 | 9 | 9.29 | 0.969 | 4.02e-7 | 112 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Possible molecular chaperone; assists the folding of proteins upon ATP hydrolysis. {ECO:0000250|UniProtKB:P40227}.;
Intolerance Scores
- loftool
- 0.786
- rvis_EVS
- 0.31
- rvis_percentile_EVS
- 72.75
Haploinsufficiency Scores
- pHI
- 0.449
- hipred
- N
- hipred_score
- 0.317
- ghis
- 0.424
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.114
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- inorganic anion transport;potassium ion transmembrane transport
- Cellular component
- chaperonin-containing T-complex
- Molecular function
- anion channel activity;ATP binding;calcium-activated potassium channel activity